Antonio Ciaccia
@aciaccia.bsky.social
Advocate for drug price transparency, competitive healthcare markets, & patient-centered care at 46brooklyn Research and 3 Axis Advisors. Dad to Franco, Marco, Vera, Enzo.
PBMs say they want low list prices for drugs.
Their new affiliated private label drug companies now have the power to do it themselves.
Instead, the generic prices are on average 33 times higher than the lowest in the market.
www.bloomberg.com/news/article...
Their new affiliated private label drug companies now have the power to do it themselves.
Instead, the generic prices are on average 33 times higher than the lowest in the market.
www.bloomberg.com/news/article...
Cigna Unit Sells Generic Drugs at Higher Prices, Report Says
A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, according to a new analysis that raises questions about the company’s role...
www.bloomberg.com
November 7, 2025 at 4:22 PM
PBMs say they want low list prices for drugs.
Their new affiliated private label drug companies now have the power to do it themselves.
Instead, the generic prices are on average 33 times higher than the lowest in the market.
www.bloomberg.com/news/article...
Their new affiliated private label drug companies now have the power to do it themselves.
Instead, the generic prices are on average 33 times higher than the lowest in the market.
www.bloomberg.com/news/article...
Everyone says they want low drug prices until actual low drug prices show up.
(except patients)
@costplusdrugs.com @mcuban.bsky.social @alexosh.bsky.social @drugchannels.bsky.social @pharmalot.bsky.social www.statnews.com/pharmalot/20...
(except patients)
@costplusdrugs.com @mcuban.bsky.social @alexosh.bsky.social @drugchannels.bsky.social @pharmalot.bsky.social www.statnews.com/pharmalot/20...
Mark Cuban is trying to shake up biosimilar pricing with a version of J&J's best-selling Stelara drug
In its bid to shake up drug pricing, the Mark Cuban Cost Plus Drug Company has reached a deal to sell a biosimilar version of Stelara, a widely prescribed treatment.
www.statnews.com
November 6, 2025 at 7:55 PM
Everyone says they want low drug prices until actual low drug prices show up.
(except patients)
@costplusdrugs.com @mcuban.bsky.social @alexosh.bsky.social @drugchannels.bsky.social @pharmalot.bsky.social www.statnews.com/pharmalot/20...
(except patients)
@costplusdrugs.com @mcuban.bsky.social @alexosh.bsky.social @drugchannels.bsky.social @pharmalot.bsky.social www.statnews.com/pharmalot/20...
You don’t say?
UnitedHealth pays its own physician groups 17% more than outside ones, study shows
The findings are similar to an analysis STAT conducted, and raise questions about why UnitedHealth pays its doctors more.
www.statnews.com
November 3, 2025 at 10:37 PM
You don’t say?
From Big 3 to just zero: Rite Aid is officially reduced to ashes as pharmacy market attrition rolls on @martyschladen.bsky.social ohiocapitaljournal.com/2025/10/13/a...
After bailing on Ohio and Michigan, Rite Aid closes completely • Ohio Capital Journal
A wave of pharmacy closures in Ohio and elsewhere appears to be deepening. Once the third-largest pharmacy chain in the United States, Rite Aid announced on its website that all of its stores are now ...
ohiocapitaljournal.com
October 13, 2025 at 8:00 PM
From Big 3 to just zero: Rite Aid is officially reduced to ashes as pharmacy market attrition rolls on @martyschladen.bsky.social ohiocapitaljournal.com/2025/10/13/a...
“Soaking high drug prices as a mechanism to lower premiums is neither a wise nor a sustainable practice.”
Acknowledge @repauchincloss.bsky.social 🎙️
www.realpharma.co/where-policy...
Acknowledge @repauchincloss.bsky.social 🎙️
www.realpharma.co/where-policy...
Where Policy Meets the Pharmacy Counter
Where Policy Meets the Pharmacy Counter Featuring Congressman Jake Auchincloss Episode Summary In this episode of RealPharma , hosts Na-Ri Oh and Ian Wendt sit down…
www.realpharma.co
October 13, 2025 at 5:13 PM
“Soaking high drug prices as a mechanism to lower premiums is neither a wise nor a sustainable practice.”
Acknowledge @repauchincloss.bsky.social 🎙️
www.realpharma.co/where-policy...
Acknowledge @repauchincloss.bsky.social 🎙️
www.realpharma.co/where-policy...
When Amazon makes moves in pharmacy – no matter how seemingly small – you should always be thinking about the long game @nyeungs.bsky.social
endpoints.news/whats-behind...
endpoints.news/whats-behind...
What's behind Amazon’s in-person pharmacy play
Amazon to install prescription medication dispensing machines at One Medical clinics, starting in Los Angeles this December, marking its first in-person pharmacy presence.
endpoints.news
October 9, 2025 at 6:24 PM
When Amazon makes moves in pharmacy – no matter how seemingly small – you should always be thinking about the long game @nyeungs.bsky.social
endpoints.news/whats-behind...
endpoints.news/whats-behind...
“American businesses should not be left to subsidize the lack of transparency, accountability and fair competition in the health care industry.”
www.washingtontimes.com/news/2025/oc...
www.washingtontimes.com/news/2025/oc...
Congress must address the health care cost crisis now
Our health care system has a pressing need for greater competition and transparency.
www.washingtontimes.com
October 8, 2025 at 11:04 PM
“American businesses should not be left to subsidize the lack of transparency, accountability and fair competition in the health care industry.”
www.washingtontimes.com/news/2025/oc...
www.washingtontimes.com/news/2025/oc...
The price is the price.
Unless it’s the other price.
Generic drug prices are going up and down – depending on your perspective.
www.46brooklyn.com/research/are...
Unless it’s the other price.
Generic drug prices are going up and down – depending on your perspective.
www.46brooklyn.com/research/are...
Are generic drug prices going up or down? Depends on which benchmark you ask — 46brooklyn Research
For the first time: Year-over-year generic drug price inflation For those unfamiliar, our team at 46brooklyn Research have a thing for tracking prescription drug prices. Not just the prices of d...
www.46brooklyn.com
October 2, 2025 at 1:29 PM
The price is the price.
Unless it’s the other price.
Generic drug prices are going up and down – depending on your perspective.
www.46brooklyn.com/research/are...
Unless it’s the other price.
Generic drug prices are going up and down – depending on your perspective.
www.46brooklyn.com/research/are...
“The immediate stock reaction across the group affirms our view this is more optics than bite.”
Good rundown on yesterday’s Trump/Pfizer rendezvous from @elaineywchen.bsky.social
www.statnews.com/2025/09/30/w...
Good rundown on yesterday’s Trump/Pfizer rendezvous from @elaineywchen.bsky.social
www.statnews.com/2025/09/30/w...
Will the White House drug-pricing deal lower costs for Americans? Experts are skeptical
Will the White House drug-pricing deal lower costs for Americans? Experts are skeptical.
www.statnews.com
October 1, 2025 at 10:36 PM
“The immediate stock reaction across the group affirms our view this is more optics than bite.”
Good rundown on yesterday’s Trump/Pfizer rendezvous from @elaineywchen.bsky.social
www.statnews.com/2025/09/30/w...
Good rundown on yesterday’s Trump/Pfizer rendezvous from @elaineywchen.bsky.social
www.statnews.com/2025/09/30/w...
If you are someone who wants more drug manufacturing in the U.S., this may please you.
If you are someone who wants lower brand drug prices in the U.S., this may tariffy you.
www.usatoday.com/story/money/...
If you are someone who wants lower brand drug prices in the U.S., this may tariffy you.
www.usatoday.com/story/money/...
Trump announced new drug tariffs. How much will you pay at the pharmacy counter?
President Donald Trump announced 100% tariffs on brand drugs. Companies that build a U.S. manufacturing plant will be exempt.
www.usatoday.com
September 26, 2025 at 6:15 PM
If you are someone who wants more drug manufacturing in the U.S., this may please you.
If you are someone who wants lower brand drug prices in the U.S., this may tariffy you.
www.usatoday.com/story/money/...
If you are someone who wants lower brand drug prices in the U.S., this may tariffy you.
www.usatoday.com/story/money/...
September 25, 2025 at 2:52 PM
There are 281 brand-name drugs with new list prices.
Here are the details.
Here are the details.
A quarterly-ish review of U.S. drug price changes — 46brooklyn Research
As a non-profit, we at 46brooklyn have made it our goal to provide insights into U.S. drug pricing data available in the public domain based upon the figures we are able to get our nerdy hands on. Whi...
www.46brooklyn.com
September 22, 2025 at 9:21 PM
There are 281 brand-name drugs with new list prices.
Here are the details.
Here are the details.
Another state attorney general digs into drug pricing bloat and dysfunction 👇
www.oag.state.va.us/media-center...
www.oag.state.va.us/media-center...
September 13, 2025 at 1:15 PM
Another state attorney general digs into drug pricing bloat and dysfunction 👇
www.oag.state.va.us/media-center...
www.oag.state.va.us/media-center...
As a long-time fan of his show, it was awesome to join Clay Farris for a discussion about American drug pricing dysfunction.
mostlymedicaid.com/medicaid-con...
mostlymedicaid.com/medicaid-con...
September 9, 2025 at 1:14 AM
As a long-time fan of his show, it was awesome to join Clay Farris for a discussion about American drug pricing dysfunction.
mostlymedicaid.com/medicaid-con...
mostlymedicaid.com/medicaid-con...
When it rains, it pours.
UnitedHealth Ongoing Criminal Probe Is Broader Than Medicare
The US Justice Department’s criminal division is digging into UnitedHealth Group Inc.’s prescription management services as well as how it reimburses its own doctors under an ongoing probe into the fi...
www.bloomberg.com
September 1, 2025 at 1:57 PM
When it rains, it pours.
“The current system is riddled with barriers to innovation, shielded by exclusivity protections and mired in anticompetitive practices — which help ensure high drug prices persist.”
@blueshieldca.bsky.social www.healthcaredive.com/news/drug-in...
@blueshieldca.bsky.social www.healthcaredive.com/news/drug-in...
Drug innovation should benefit patients. PBMs are preventing that from happening.
Health plans should directly contract with drug manufacturers to provide medications at transparent and affordable prices, argues Kathy Chang, head of trade relations at Blue Shield of California.
www.healthcaredive.com
August 23, 2025 at 5:08 PM
“The current system is riddled with barriers to innovation, shielded by exclusivity protections and mired in anticompetitive practices — which help ensure high drug prices persist.”
@blueshieldca.bsky.social www.healthcaredive.com/news/drug-in...
@blueshieldca.bsky.social www.healthcaredive.com/news/drug-in...
Reposted by Antonio Ciaccia
Potential positives and negatives aside, pharm-to-table is a band-aid on a mortal wound. @aciaccia.bsky.social www.ajmc.com/view/direct-...
Direct-to-Patient Apixaban Program Aims to Expand Access, Lower Out-of-Pocket Costs
Apixaban would still cost patients 9 times more through the Eliquis 360 Support program than with commercial insurance.
www.ajmc.com
August 17, 2025 at 11:49 AM
Potential positives and negatives aside, pharm-to-table is a band-aid on a mortal wound. @aciaccia.bsky.social www.ajmc.com/view/direct-...
Behold the power of whistleblowers: $289.9 million set to come back to US government and certified G, Sarah Behnke
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs.
www.reuters.com
August 20, 2025 at 6:02 PM
Behold the power of whistleblowers: $289.9 million set to come back to US government and certified G, Sarah Behnke
The policy ground is shifting on the 340B program, which means the system's current winners and losers have their eyes on how proposed changes could impact their financial realities
340B rebate pilot tees up healthcare industry firestorm
Drugmakers want to convert 340B discounts to rebates under a federal pilot program set to launch in January. Providers are anxious.
www.modernhealthcare.com
August 18, 2025 at 9:37 PM
The policy ground is shifting on the 340B program, which means the system's current winners and losers have their eyes on how proposed changes could impact their financial realities
So essentially, the early yield of the push to bring US drug prices in line with other nations is just exporting American drug pricing distortions.
Eli Lilly says it will raise drug prices in Europe to ‘make them lower’ in U.S.
Eli Lilly said it would raise drug prices in Europe to "make them lower" in U.S., though the actual impact on most patients abroad remains unclear.
www.statnews.com
August 14, 2025 at 6:12 PM
So essentially, the early yield of the push to bring US drug prices in line with other nations is just exporting American drug pricing distortions.
“We’re trying to disrupt an industry that needs disrupted.”
Testify, Mark.
@gianteagle.bsky.social @mcuban.bsky.social @costplusdrugs.com
triblive.com/news/health-...
Testify, Mark.
@gianteagle.bsky.social @mcuban.bsky.social @costplusdrugs.com
triblive.com/news/health-...
'We're trying to disrupt an industry': Mark Cuban touts pharmacy deal with Giant Eagle
Mark Cuban, the billionaire and Western Pennsylvania native now knee-deep in the pharmaceutical industry, offered strong words Wednesday toward the pharmacy benefit managers some say are bleeding drug...
triblive.com
August 7, 2025 at 1:38 PM
“We’re trying to disrupt an industry that needs disrupted.”
Testify, Mark.
@gianteagle.bsky.social @mcuban.bsky.social @costplusdrugs.com
triblive.com/news/health-...
Testify, Mark.
@gianteagle.bsky.social @mcuban.bsky.social @costplusdrugs.com
triblive.com/news/health-...
Had a great discussion with @matthewstoller.bsky.social and @ddayen.bsky.social about PBMs, pharmacies, manufacturers, Medicaid, and how misguided public policies have yielded bloated drug prices and an over-reliance on conflicted intermediaries
www.organizedmoney.fm/p/the-pbm-hi...
www.organizedmoney.fm/p/the-pbm-hi...
The PBM Hitman
Welcome to the podcast Organized Money.
www.organizedmoney.fm
July 30, 2025 at 1:39 AM
Had a great discussion with @matthewstoller.bsky.social and @ddayen.bsky.social about PBMs, pharmacies, manufacturers, Medicaid, and how misguided public policies have yielded bloated drug prices and an over-reliance on conflicted intermediaries
www.organizedmoney.fm/p/the-pbm-hi...
www.organizedmoney.fm/p/the-pbm-hi...
Decades after retreating from their former marriages, PBMs are blending their DNA with drug companies once again, this time through private labelling.
Here's what it means for the costs of medicines.
Our latest:
Here's what it means for the costs of medicines.
Our latest:
How PBMs can use private-labelled drug products as a great escape from anti-steering policies — 46brooklyn Research
Across every corner of U.S. healthcare, from end-of-life care to reproductive rights, patient choice sits squarely in the middle of many health policy questions. From a certain point of view, patient ...
www.46brooklyn.com
July 22, 2025 at 7:34 PM
Decades after retreating from their former marriages, PBMs are blending their DNA with drug companies once again, this time through private labelling.
Here's what it means for the costs of medicines.
Our latest:
Here's what it means for the costs of medicines.
Our latest: